Latest Medical research News

Russian medical worker, right, administers a shot of Russia's Sputnik V coronavirus vaccine in Moscow, Russia, Saturday, Dec. 5, 2020. Thousands of doctors, teachers and others in high-risk groups have signed up for COVID-19 vaccinations in Moscow starting Saturday, a precursor to a sweeping Russia-wide immunization effort. (AP Photo/Pavel Golovkin)

Moscow opens dozens of coronavirus vaccination centers

Dec. 5, 2020 1:50 PM EST

MOSCOW (AP) — The city of Moscow opening 70 vaccination facilities where thousands of doctors, teachers and others in high-risk groups had signed up to receive COVID-19 vaccines starting Saturday, a precursor to a sweeping Russia-wide immunization effort. The centers in the capital started giving shots to...

This July 2019 image provided by the Sarah Cannon Research Institute shows Victoria Gray on her infusion day during a gene editing trial for sickle cell disease at the Sarah Cannon Research Institute and The Children's Hospital At TriStar Centennial in Nashville. Since her treatment, Gray has weaned herself from pain medications she depended on to manage her symptoms. (Anthem Pictures/Sarah Cannon Research Institute via AP)

Gene-editing treatment shows promise for sickle cell disease

Dec. 5, 2020 12:31 PM EST

Scientists are seeing promising early results from the first studies testing gene editing for painful, inherited blood disorders that plague millions worldwide. Doctors hope the one-time treatment, which involves permanently altering DNA in blood cells with a tool called CRISPR, may treat and possibly cure sickle...

FILE - In this file photo dated Wednesday, Oct. 18, 2017, World Health Organization President Tedros Adhanom speaks to the press during the World Health Organization conference on noncommunicable diseases in Montevideo, Uruguay. At a meeting of WHO’s member states, Monday Nov. 9, 2020, WHO director-general Tedros Adhanom Ghebreyesus said he welcomed “any and all attempts to strengthen the organization...for the sake of the people we serve.

UN health chief: World can start dreaming of pandemic's end

Dec. 4, 2020 11:43 PM EST

UNITED NATIONS (AP) — The U.N. health chief declared Friday that positive results from coronavirus vaccine trials mean the world “can begin to dream about the end of the pandemic,” but he said rich and powerful nations must not trample the poor and marginalized “in the stampede for...

Chinese researcher pleads to lying in cancer-smuggling case

Dec. 3, 2020 4:23 PM EST

BOSTON (AP) — A medical researcher accused of trying to smuggle vials of cancer research material out of the U.S. to his native China by hiding it in a sock inside his luggage pleaded guilty to a related charge Thursday, federal prosecutors in Boston said. Zaosong Zheng, 31, pleaded guilty to making false...

FILE - In this Oct. 9, 2020 file photo, a health worker administers the first dose of a COVID-19 vaccine currently on phase III clinical trials to Cem Gun, an Emergency Medicine Physician, at the Acibadem Hospital in Istanbul, Friday, Oct. 9, 2020. Turkish health minister Fahrettin Koca, who had previously announced an agreement with Chinese biopharmaceutical company Sinovac Biotech for 50 million doses of CoronaVac, said in a statement late Wednesday, Dec. 2, 2020, that the first shipment of the inactivated vaccine will arrive in Turkey after Dec. 11. (AP Photo/Emrah Gurel, file)

Turkey announces vaccination plan for Chinese CoronaVac

Dec. 3, 2020 9:29 AM EST

ISTANBUL (AP) — Turkey’s health minister has announced a plan to start using an experimental Chinese COVID-19 vaccine later this month amid a surge in infections and deaths. Fahrettin Koca had previously announced an agreement with China’s Sinovac Biotech for 50 million doses of CoronaVac,...

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore.  Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Courtesy of University of Maryland School of Medicine via AP, File)

Britain OKs Pfizer vaccine and will begin shots within days

Dec. 2, 2020 6:45 PM EST

LONDON (AP) — Britain became the first country in the world to authorize a rigorously tested COVID-19 vaccine Wednesday and could be dispensing shots within days — a historic step toward eventually ending the outbreak that has killed more than 1.4 million people around the globe. In giving the...

Russian President Vladimir Putin attends a meeting via video conference at the Novo-Ogaryovo residence outside Moscow, Russia, Wednesday, Dec. 2, 2020. Russian President Vladimir Putin announced start of large-scale vaccination of medics and teachers against COVID next week. Speaking during an online meeting dedicated to inauguration of new hospitals for coronavirus patients built by Russian Defense Ministry, Putin said Russia has enough capacity to start

Putin orders 'large-scale' COVID-19 vaccination in Russia

Dec. 2, 2020 3:24 PM EST

MOSCOW (AP) — President Vladimir Putin on Wednesday ordered a “large-scale” COVID-19 immunization campaign to start by late next week, with doctors and teachers set to be first in line to get a Russian-designed vaccine that has yet to complete the advanced studies needed to ensure its...

In this Monday, Nov. 9, 2020 photo, the company sign of BioNtech stands in front of the companies headquarters in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Arne Dedert/dpa via AP)

Who, when and how? A look at the UK's vaccination rollout

Dec. 2, 2020 2:21 PM EST

LONDON (AP) — British regulators have become the first to authorize the COVID-19 vaccine developed by American drugmaker Pfizer and Germany’s BioNTech for emergency use. Because trials of the vaccine have shown it has 95% efficacy, there is acute interest in how the U.K. plans to implement...

FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Hans Pennink, File)

US panel: 1st vaccines to health care workers, nursing homes

Dec. 2, 2020 1:52 AM EST

NEW YORK (AP) — Health care workers and nursing home residents should be at the front of the line when the first coronavirus vaccine shots become available, an influential government advisory panel said Tuesday. The panel voted 13-1 to recommend those groups get priority in the first days of any coming...

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)

EU eyes Dec 29 approval for 1st virus vaccine, later than US

Dec. 1, 2020 1:47 PM EST

BERLIN (AP) — The European Union drug agency said Tuesday it may need four more weeks to approve its first coronavirus vaccine, even as authorities in the United States and Britain continue to aim for a green light before Christmas. The European Medicines Agency plans to convene a meeting by Dec. 29 to...